Iannazzo S, Mannucci E, Mantovani L. [Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]. FE [Internet]. 2016 Mar. 31 [cited 2025 Jul. 23];17(1):19-27. Available from: https://provafe.seedstm.com/index.php/FE/article/view/1238